Brian Agan, MD

Brian K Agan, MD

Name: Brian K Agan, MD

USU Department of Primary Appointment: 
Preventive Medicine and Biostatistics
Deputy Science Director; HIV Research Area Director
Faculty Rank: 
Associate Professor
Uniformed Services University of the Health Sciences, Bethesda, MD

Research Interests:

Office Phone: 
(301) 816-8446


BA - Chemistry; Colorado College, Colorado Springs, CO
MD - University of Colorado School of Medicine, Denver, CO
Internship & Residency - Internal Medicine; Wilford Hall USAF Medical Center, San Antonio, TX
Fellowship - Infectious Diseases; Wilford Hall USAF Medical Center, San Antonio, TX


  • Freiberg MS, Bebu I, Tracy R, So-Armah K, Okulicz J, Ganesan A, Armstrong A, O'Bryan T, Rimland D, Justice AC, Agan BK; Infectious Disease Clinical Research Program HIV Working Group. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events. PLoS One. 2016 Apr 18;11(4):e0152588.
  • Emuren L, Welles S, Evans AA, Polansky M, Okulicz JF, Macalino G, Agan BK; Infectious Disease Clinical Research Program HIV Working Group. Health-related quality of life among military HIV patients on antiretroviral therapy. PLoS One 2017 Jun 7;12(6):e0178953.
  • Crum-Cianflone NF, Won S, Lee R, Lalani T, Ganesan A, Burgess T, Agan BK. Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults. Vaccine 2016 Sep 22;34(41):5040-6.
  • Deiss R, Bower RJ, Co E, Mesner O, Sanchez JL, Masel J, Ganesan A, Macalino GE, Agan BK. The Association between Sexually Transmitted Infections, Length of Service and Other Demographic Factors in the U.S. Military. PLoS One 2016 Dec 9;11(12):e0167892.
  • Masel J, Deiss RG, Wang X, Sanchez JL, Ganesan A, Macalino GE, Gaydos JC, Kortepeter MG, Agan BK. Seroprevalence and Seroincidence of Herpes Simplex Virus (2006-2010), Syphilis (2006-2010), and Vaccine-Preventable Human Papillomavirus Subtypes (2000-2010) Among US Military Personnel. Sex Transm Dis 2015 May;42(5):253-8.
  • Okulicz JF, Le TD, Agan BK, Camargo JF, Landrum ML, Wright E, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD, Little SJ, Clark RA, He W, Ahuja SK. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med 2015 Jan;175(1):88-99.
  • Crum-Cianflone NF, Wang X, Ganesan A, Okulicz J, Weintrob A, Lalani T, Agan B. HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults. AIDS Res Hum Retroviruses 2015 May;31(5):514-8.
  • Ganesan A, Mesner O, Okulicz JF, O'Bryan T, Deiss RG, Lalani T, Whitman TJ, Weintrob AC, Macalino G, Agan BK; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015 Feb 15;60(4):653-60.
  • Okulicz JF, Mesner O, Ganesan A, O'Bryan TA, Deiss RG, Agan BK. Hepatitis B Vaccine Responsiveness and Clinical Outcomes in HIV Controllers. PLoS One 2014 Aug 21;9(8):e105591.
  • Johnson EN, Roediger MP, Landrum ML, Crum-Cianflone NF, Weintrob AC, Ganesan A, Okulicz JF, Macalino GE, Agan BK; Infectious Disease Clinical Research Program HIV Working Group. Race/ethnicity and HAART initiation in a military HIV infected cohort. AIDS Res Ther 2014 Jan 24;11(1):10.